A Trial of Lu AF82422 in Participants With Multiple System Atrophy (MSA)
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 360
- Registration Number
- NCT06706622
- Locations
- ๐บ๐ธ
University Nebraska Medical Center, Omaha, Nebraska, United States
๐บ๐ธColumbia University Medical Center - The Neurological Institute of New York, New York, New York, United States
๐ฆ๐บWestmead Hospital, Westmead, New South Wales, Australia
A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 24
- Registration Number
- NCT06258720
- Locations
- ๐จ๐ณ
Zhongshan Hospital Fudan University, Shanghai, China
A Study of Lu AF82422 in Participants With Multiple System Atrophy
- Conditions
- Multiple System Atrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 64
- Registration Number
- NCT05104476
- Locations
- ๐บ๐ธ
The Parkinson's and Movement Disorder Institute, Fountain Valley, California, United States
๐บ๐ธUniversity of California - San Diego, La Jolla, California, United States
๐บ๐ธUCSF Memory and Aging Center, San Francisco, California, United States
Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 74
- Registration Number
- NCT03611569
- Locations
- ๐บ๐ธ
California Clinical Trials Medical Group (CCTMG), Glendale, California, United States
๐บ๐ธReserach Center of America, Hollywood, Florida, United States
๐บ๐ธPPD, Orlando, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.